Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman

Laura Bonanno, F. Calabrese, Giorgia Nardo, Daniele Calistri, Michela Tebaldi, Gianluca Tedaldi, Valentina Polo, Stefania Edith Vuljan, Adolfo Gino Favaretto, Pierfranco Conte, Alberto Amadori, Federico Rea, Stefano Indraccolo

Research output: Contribution to journalArticle

Abstract

Discrimination of multifocal primary lung cancers from lung metastases is crucial to allow for an appropriate clinical management. We report here a case of multifocal lung adenocarcinomas with different morphological and molecular patterns. Radical surgery of one lung nodule was performed at the time of diagnosis, and subsequently on two other lung nodules. At the time of distant relapse, biopsy was repeated for molecular characterization. The patient was treated with EGFR tyrosine kinase inhibitor according to the detection of EGFR exon 21 mutation in metastatic sample and in one of the three lung tumors, characterized by lower mutated allele frequency. The progression free survival was three months according to radiological criteria and the treatment was provided for six months, until clinical progression. Following the assessment of EGFR mutations by pyrosequencing, tumor samples were analyzed by a 30-gene next generation sequencing (NGS) panel, allowing to study intra- and inter-tumor heterogeneity and to confirm the three lung tumors as independent. Different molecular profiles of synchronous tumors and identical EGFR, PIK3CA and TP53 mutations in one of three primary lung tumors and the metachronous metastasis were identified.In conclusion, morphological and molecular characterization of multiple lung nodules by NGS may help to define synchronous and metachronous adenocarcinomas, thus affecting surgical indication and systemic treatment. Intratumor heterogeneity may be associated with differential sensitivity to targeted treatment.

Original languageEnglish
Pages (from-to)52-55
Number of pages4
JournalLung Cancer
Volume96
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Genetic Heterogeneity
Lung
Neoplasms
Mutation
Lung Neoplasms
Neoplasm Metastasis
Adenocarcinoma of lung
Gene Frequency
Protein-Tyrosine Kinases
Disease-Free Survival
Exons
Adenocarcinoma
Therapeutics
Biopsy
Recurrence
Genes

Keywords

  • EGFR
  • Multifocal lung tumors
  • Mutate allele frequency
  • Next generation sequencing
  • Non-small cell lung cancer
  • Pathology

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Morphological and genetic heterogeneity in multifocal lung adenocarcinoma : The case of a never-smoker woman. / Bonanno, Laura; Calabrese, F.; Nardo, Giorgia; Calistri, Daniele; Tebaldi, Michela; Tedaldi, Gianluca; Polo, Valentina; Vuljan, Stefania Edith; Favaretto, Adolfo Gino; Conte, Pierfranco; Amadori, Alberto; Rea, Federico; Indraccolo, Stefano.

In: Lung Cancer, Vol. 96, 01.06.2016, p. 52-55.

Research output: Contribution to journalArticle

@article{f844f79e9e524c67965e2617a7421b25,
title = "Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman",
abstract = "Discrimination of multifocal primary lung cancers from lung metastases is crucial to allow for an appropriate clinical management. We report here a case of multifocal lung adenocarcinomas with different morphological and molecular patterns. Radical surgery of one lung nodule was performed at the time of diagnosis, and subsequently on two other lung nodules. At the time of distant relapse, biopsy was repeated for molecular characterization. The patient was treated with EGFR tyrosine kinase inhibitor according to the detection of EGFR exon 21 mutation in metastatic sample and in one of the three lung tumors, characterized by lower mutated allele frequency. The progression free survival was three months according to radiological criteria and the treatment was provided for six months, until clinical progression. Following the assessment of EGFR mutations by pyrosequencing, tumor samples were analyzed by a 30-gene next generation sequencing (NGS) panel, allowing to study intra- and inter-tumor heterogeneity and to confirm the three lung tumors as independent. Different molecular profiles of synchronous tumors and identical EGFR, PIK3CA and TP53 mutations in one of three primary lung tumors and the metachronous metastasis were identified.In conclusion, morphological and molecular characterization of multiple lung nodules by NGS may help to define synchronous and metachronous adenocarcinomas, thus affecting surgical indication and systemic treatment. Intratumor heterogeneity may be associated with differential sensitivity to targeted treatment.",
keywords = "EGFR, Multifocal lung tumors, Mutate allele frequency, Next generation sequencing, Non-small cell lung cancer, Pathology",
author = "Laura Bonanno and F. Calabrese and Giorgia Nardo and Daniele Calistri and Michela Tebaldi and Gianluca Tedaldi and Valentina Polo and Vuljan, {Stefania Edith} and Favaretto, {Adolfo Gino} and Pierfranco Conte and Alberto Amadori and Federico Rea and Stefano Indraccolo",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.lungcan.2016.03.009",
language = "English",
volume = "96",
pages = "52--55",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Morphological and genetic heterogeneity in multifocal lung adenocarcinoma

T2 - The case of a never-smoker woman

AU - Bonanno, Laura

AU - Calabrese, F.

AU - Nardo, Giorgia

AU - Calistri, Daniele

AU - Tebaldi, Michela

AU - Tedaldi, Gianluca

AU - Polo, Valentina

AU - Vuljan, Stefania Edith

AU - Favaretto, Adolfo Gino

AU - Conte, Pierfranco

AU - Amadori, Alberto

AU - Rea, Federico

AU - Indraccolo, Stefano

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Discrimination of multifocal primary lung cancers from lung metastases is crucial to allow for an appropriate clinical management. We report here a case of multifocal lung adenocarcinomas with different morphological and molecular patterns. Radical surgery of one lung nodule was performed at the time of diagnosis, and subsequently on two other lung nodules. At the time of distant relapse, biopsy was repeated for molecular characterization. The patient was treated with EGFR tyrosine kinase inhibitor according to the detection of EGFR exon 21 mutation in metastatic sample and in one of the three lung tumors, characterized by lower mutated allele frequency. The progression free survival was three months according to radiological criteria and the treatment was provided for six months, until clinical progression. Following the assessment of EGFR mutations by pyrosequencing, tumor samples were analyzed by a 30-gene next generation sequencing (NGS) panel, allowing to study intra- and inter-tumor heterogeneity and to confirm the three lung tumors as independent. Different molecular profiles of synchronous tumors and identical EGFR, PIK3CA and TP53 mutations in one of three primary lung tumors and the metachronous metastasis were identified.In conclusion, morphological and molecular characterization of multiple lung nodules by NGS may help to define synchronous and metachronous adenocarcinomas, thus affecting surgical indication and systemic treatment. Intratumor heterogeneity may be associated with differential sensitivity to targeted treatment.

AB - Discrimination of multifocal primary lung cancers from lung metastases is crucial to allow for an appropriate clinical management. We report here a case of multifocal lung adenocarcinomas with different morphological and molecular patterns. Radical surgery of one lung nodule was performed at the time of diagnosis, and subsequently on two other lung nodules. At the time of distant relapse, biopsy was repeated for molecular characterization. The patient was treated with EGFR tyrosine kinase inhibitor according to the detection of EGFR exon 21 mutation in metastatic sample and in one of the three lung tumors, characterized by lower mutated allele frequency. The progression free survival was three months according to radiological criteria and the treatment was provided for six months, until clinical progression. Following the assessment of EGFR mutations by pyrosequencing, tumor samples were analyzed by a 30-gene next generation sequencing (NGS) panel, allowing to study intra- and inter-tumor heterogeneity and to confirm the three lung tumors as independent. Different molecular profiles of synchronous tumors and identical EGFR, PIK3CA and TP53 mutations in one of three primary lung tumors and the metachronous metastasis were identified.In conclusion, morphological and molecular characterization of multiple lung nodules by NGS may help to define synchronous and metachronous adenocarcinomas, thus affecting surgical indication and systemic treatment. Intratumor heterogeneity may be associated with differential sensitivity to targeted treatment.

KW - EGFR

KW - Multifocal lung tumors

KW - Mutate allele frequency

KW - Next generation sequencing

KW - Non-small cell lung cancer

KW - Pathology

UR - http://www.scopus.com/inward/record.url?scp=84962164603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962164603&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2016.03.009

DO - 10.1016/j.lungcan.2016.03.009

M3 - Article

VL - 96

SP - 52

EP - 55

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -